Delivery Order SPE2DB22D2218-SPE2DB25FR2PL
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,102.24 firm fixed-price contract is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The award has a June 2025 completion date and is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $1,390.44 firm fixed-price contract is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has a completion date of June 6, 2025 and is not set aside for any specific business category. AmerisourceBergen also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $6,856.87 firm-fixed-price contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of June 30, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,947.55 contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The order has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.98 firm fixed-price delivery order is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of May 14, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,001.46, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,681.89 firm fixed-price contract is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication, with a performance period through June 6, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a $18,859.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication, with a period of performance through February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $41,768.23, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes treatment medication. The contract is a firm fixed-price, non-set-aside delivery order with a completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a $5,808.54 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty medication used for diabetes management. The delivery order has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...